Suppr超能文献

结合前列腺癌风险指数(PRIX)与继发性循环前列腺细胞的存在情况以预测前列腺癌根治术后生化复发风险

Combining the Prostate Cancer Risk Index (PRIX) with the Presence of Secondary Circulating Prostate Cells to Predict the Risk of Biochemical Failure after Radical Prostatectomy for Prostate Cancer.

作者信息

Murray Nigel P, Aedo Socrates, Fuentealba Cynthia, Reyes Eduardo, Jacob Omar

机构信息

CTC Unit, Faculty of Medicine, University Finis Terrae, Chile. Email:

出版信息

Asian Pac J Cancer Prev. 2018 Dec 25;19(12):3375-3381. doi: 10.31557/APJCP.2018.19.12.3375.

Abstract

Introduction: The use of pre- and post-surgery variables has been used to create nomograms in order to identify patients at high risk of treatment failure. The PRIX nomogram is one such device; we compare the PRIX nomogram with the presence of secondary circulating prostate cells to predict those men who will undergo treatment failure. Methods and Patients: Men who underwent radical prostatectomy for prostate cancer entered the study. The PRIX score was calculated from the total serum PSA pre-surgery, the biopsy Gleason score and clinical stage. Circulating prostate cells were detected from venous blood one month after surgery, using differential gel centrifugation and standard immunocytochemistry with anti-PSA. A test was considered positive when 1 CPC/blood sample was detected. Patients were followed up for five years and biochemical failure was defined as a serum PSA >0.2ng/ml. Kaplan-Meier and Cox proportional models were used to calculate survival curves. Results: 321 men participated, of whom 131 (40.8%) underwent biochemical failure within 5 years. A higher PRIX score was associated with increased failure risk, as was the presence of CPCs. The predictive power of CPCs was significantly higher than the PRIX score. Combining the two methods, for equal PRIX scores, scores but CPC positive had a worse biochemical failure free survival than men with high PRIX scores but CPC negative. For men with PRIX scores of ≥4 the use of CPC detection did not aid in the clinical decision making process. For those with PRIX scores of 0 and 1, CPC detection identified men with a high risk of treatment failure. Conclusions: The combined PRIX/CPC score improved the predictive values of men at high risk of biochemical failure. Both are simple systems that could be incorporated in a general hospital. Further multicenter studies are warranted to confirm these results.

摘要

引言

手术前后变量已被用于创建列线图,以识别治疗失败风险高的患者。PRIX列线图就是这样一种工具;我们将PRIX列线图与继发性循环前列腺细胞的存在情况进行比较,以预测那些将经历治疗失败的男性。

方法与患者

因前列腺癌接受根治性前列腺切除术的男性进入本研究。PRIX评分由术前总血清PSA、活检Gleason评分和临床分期计算得出。术后1个月从静脉血中检测循环前列腺细胞,采用差异凝胶离心法和抗PSA标准免疫细胞化学法。当每血样检测到1个循环前列腺细胞(CPC)时,试验被认为呈阳性。对患者进行了5年的随访,生化失败定义为血清PSA>0.2ng/ml。采用Kaplan-Meier和Cox比例模型计算生存曲线。

结果

321名男性参与研究,其中131名(40.8%)在5年内发生生化失败。较高的PRIX评分与失败风险增加相关,CPC的存在也是如此。CPC的预测能力显著高于PRIX评分。将两种方法结合起来,对于相同的PRIX评分,CPC阳性的患者无生化失败生存期比PRIX评分高但CPC阴性的患者更差。对于PRIX评分≥4的男性,使用CPC检测无助于临床决策过程。对于PRIX评分为0和1的男性,CPC检测可识别出治疗失败风险高的男性。

结论

PRIX/CPC联合评分提高了生化失败高风险男性的预测价值。两者都是简单的系统,可纳入综合医院。有必要进行进一步的多中心研究以证实这些结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71cc/6428563/702e463d13f1/APJCP-19-3375-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验